FDA Approves Generic Pregabalin Capsules to Treat Fibromyalgia, Chronic Pain Conditions

FDA Approves Generic Pregabalin Capsules to Treat Fibromyalgia, Chronic Pain Conditions
The U.S. Food and Drug Administration (FDA) has approved generic pregabalin capsules for the treatment of fibromyalgia and other medical conditions associated with chronic pain. The FDA granted the approvals to Alembic Pharmaceuticals, Alkem Laboratories, Amneal PharmaceuticalsDr. Reddy's Laboratories, InvaGen Pharmaceuticals, MSN Laboratories Ltd., Rising Pharmaceuticals, Sciegen Pharmaceuticals, and Teva Pharmaceuticals. Pregabalin is the AB generic equivalent to Pfizer's Lyrica, an anti-epileptic drug (anticonvulsant) that has been approved by the FDA for the treatment of fibromyalgia and neuropathic (nerve) pain associated with diabetes (diabetic neuropathy), herpes zoster (post-herpetic neuralgia), or
Subscribe or to access all post and page content.